{"id":"https://openalex.org/W7225835259","doi":"https://doi.org/10.7759/cureus.119448","title":"Unilateral Calf Swelling and Skin Induration During Pembrolizumab-Based Neoadjuvant Therapy for Triple-Negative Breast Cancer: A Case Report","display_name":"Unilateral Calf Swelling and Skin Induration During Pembrolizumab-Based Neoadjuvant Therapy for Triple-Negative Breast Cancer: A Case Report","publication_year":2026,"publication_date":"2026-11-10","ids":{"openalex":"https://openalex.org/W7225835259","doi":"https://doi.org/10.7759/cureus.119448"},"language":"en","primary_location":{"id":"doi:10.7759/cureus.119448","doi":"https://doi.org/10.7759/cureus.119448","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.119448","pdf_url":"https://www.cureus.com/articles/535740-unilateral-calf-swelling-and-skin-induration-during-pembrolizumab-based-neoadjuvant-therapy-for-triple-negative-breast-cancer-a-case-report.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.cureus.com/articles/535740-unilateral-calf-swelling-and-skin-induration-during-pembrolizumab-based-neoadjuvant-therapy-for-triple-negative-breast-cancer-a-case-report.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029091701","display_name":"Navin Mathiyalagan","orcid":"https://orcid.org/0009-0006-5744-9820","observed_orcids":["https://orcid.org/0009-0006-5744-9820"]},"institutions":[{"id":"https://openalex.org/I2802921333","display_name":"Nottingham City Hospital","ror":"https://ror.org/0022b3c04","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1334287468","https://openalex.org/I2802921333"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Navin Mathiyalagan","raw_affiliation_strings":[". Medical Oncology , Nottingham City Hospital , Nottingham , GBR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". Medical Oncology , Nottingham City Hospital , Nottingham , GBR","institution_ids":["https://openalex.org/I2802921333"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5138172154","display_name":"Sarah Khan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802921333","display_name":"Nottingham City Hospital","ror":"https://ror.org/0022b3c04","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1334287468","https://openalex.org/I2802921333"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sarah Khan","raw_affiliation_strings":[". Medical Oncology , Nottingham City Hospital , Nottingham , GBR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". Medical Oncology , Nottingham City Hospital , Nottingham , GBR","institution_ids":["https://openalex.org/I2802921333"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035870209","display_name":"Muhammad Adeel Sarwar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334287468","display_name":"Nottingham University Hospitals NHS Trust","ror":"https://ror.org/05y3qh794","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1334287468"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Muhammad Adeel Sarwar","raw_affiliation_strings":[". Medical Oncology , Nottingham University Hospitals NHS Trust , Nottingham , GBR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". Medical Oncology , Nottingham University Hospitals NHS Trust , Nottingham , GBR","institution_ids":["https://openalex.org/I1334287468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037145731","display_name":"Rahul Eric","orcid":"https://orcid.org/0009-0000-8628-6545","observed_orcids":["https://orcid.org/0009-0000-8628-6545"]},"institutions":[{"id":"https://openalex.org/I1334287468","display_name":"Nottingham University Hospitals NHS Trust","ror":"https://ror.org/05y3qh794","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1334287468"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rahul Eric","raw_affiliation_strings":[". Medical Oncology , Nottingham University Hospitals NHS Trust , Nottingham , GBR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". Medical Oncology , Nottingham University Hospitals NHS Trust , Nottingham , GBR","institution_ids":["https://openalex.org/I1334287468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073161449","display_name":"Hui Xian Tan","orcid":"https://orcid.org/0000-0001-5340-5042","observed_orcids":["https://orcid.org/0000-0001-5340-5042"]},"institutions":[{"id":"https://openalex.org/I1334287468","display_name":"Nottingham University Hospitals NHS Trust","ror":"https://ror.org/05y3qh794","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1334287468"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Hui Xian Tan","raw_affiliation_strings":[". Medical Oncology , Nottingham University Hospitals NHS Trust , Nottingham , GBR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". Medical Oncology , Nottingham University Hospitals NHS Trust , Nottingham , GBR","institution_ids":["https://openalex.org/I1334287468"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113157283","display_name":"Mahnoor Fakhar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802921333","display_name":"Nottingham City Hospital","ror":"https://ror.org/0022b3c04","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1334287468","https://openalex.org/I2802921333"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Mahnoor Fakhar","raw_affiliation_strings":[". Medical Oncology , Nottingham City Hospital , Nottingham , GBR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". Medical Oncology , Nottingham City Hospital , Nottingham , GBR","institution_ids":["https://openalex.org/I2802921333"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5136772454","display_name":"Muhammad Bilal Zafar Ansari","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802921333","display_name":"Nottingham City Hospital","ror":"https://ror.org/0022b3c04","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1334287468","https://openalex.org/I2802921333"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Muhammad B Ansari","raw_affiliation_strings":[". Medical Oncology , Nottingham City Hospital , Nottingham , GBR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". Medical Oncology , Nottingham City Hospital , Nottingham , GBR","institution_ids":["https://openalex.org/I2802921333"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5051106910","display_name":"Sani Ul Hassan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334287468","display_name":"Nottingham University Hospitals NHS Trust","ror":"https://ror.org/05y3qh794","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1334287468"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sani U Hassan","raw_affiliation_strings":[". Medical Oncology , Nottingham University Hospitals NHS Trust , Nottingham , GBR"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". Medical Oncology , Nottingham University Hospitals NHS Trust , Nottingham , GBR","institution_ids":["https://openalex.org/I1334287468"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8217999935150146,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8217999935150146,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12600","display_name":"Eosinophilic Disorders and Syndromes","score":0.06710000336170197,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.04910000041127205,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.987500011920929},{"id":"https://openalex.org/C2778456530","wikidata":"https://www.wikidata.org/wiki/Q2325206","display_name":"Eosinophilic fasciitis","level":3,"score":0.7814000248908997},{"id":"https://openalex.org/C2780886150","wikidata":"https://www.wikidata.org/wiki/Q152234","display_name":"Edema","level":2,"score":0.5412999987602234},{"id":"https://openalex.org/C2776715498","wikidata":"https://www.wikidata.org/wiki/Q11426176","display_name":"Prednisolone","level":2,"score":0.5254999995231628},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.5138999819755554},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.4535999894142151},{"id":"https://openalex.org/C2777217379","wikidata":"https://www.wikidata.org/wiki/Q1870975","display_name":"Fasciitis","level":2,"score":0.4424999952316284},{"id":"https://openalex.org/C2776804153","wikidata":"https://www.wikidata.org/wiki/Q210420","display_name":"Corticosteroid","level":2,"score":0.4377000033855438},{"id":"https://openalex.org/C2781232998","wikidata":"https://www.wikidata.org/wiki/Q1433212","display_name":"Myositis","level":2,"score":0.41780000925064087},{"id":"https://openalex.org/C2777482430","wikidata":"https://www.wikidata.org/wiki/Q7168709","display_name":"Peripheral edema","level":3,"score":0.35519999265670776},{"id":"https://openalex.org/C2777129736","wikidata":"https://www.wikidata.org/wiki/Q505142","display_name":"Eosinophilia","level":2,"score":0.3336000144481659},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.3292999863624573},{"id":"https://openalex.org/C2776670291","wikidata":"https://www.wikidata.org/wiki/Q1779300","display_name":"Connective tissue disease","level":4,"score":0.31310001015663147},{"id":"https://openalex.org/C2778292576","wikidata":"https://www.wikidata.org/wiki/Q6991934","display_name":"Neoadjuvant therapy","level":4,"score":0.3068999946117401},{"id":"https://openalex.org/C2775930923","wikidata":"https://www.wikidata.org/wiki/Q12859063","display_name":"Metastatic breast cancer","level":4,"score":0.29089999198913574},{"id":"https://openalex.org/C2778311097","wikidata":"https://www.wikidata.org/wiki/Q5903784","display_name":"Hormonal therapy","level":4,"score":0.2757999897003174},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.27399998903274536},{"id":"https://openalex.org/C2775934546","wikidata":"https://www.wikidata.org/wiki/Q179991","display_name":"Biopsy","level":2,"score":0.27059999108314514},{"id":"https://openalex.org/C143409427","wikidata":"https://www.wikidata.org/wiki/Q161238","display_name":"Magnetic resonance imaging","level":2,"score":0.26809999346733093},{"id":"https://openalex.org/C2778540859","wikidata":"https://www.wikidata.org/wiki/Q152234","display_name":"Swelling","level":2,"score":0.2662999927997589},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.2619999945163727},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.2596000134944916},{"id":"https://openalex.org/C36880943","wikidata":"https://www.wikidata.org/wiki/Q409458","display_name":"Creatine kinase","level":2,"score":0.25459998846054077},{"id":"https://openalex.org/C198451711","wikidata":"https://www.wikidata.org/wiki/Q327657","display_name":"Rheumatology","level":2,"score":0.2533999979496002}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.7759/cureus.119448","doi":"https://doi.org/10.7759/cureus.119448","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.119448","pdf_url":"https://www.cureus.com/articles/535740-unilateral-calf-swelling-and-skin-induration-during-pembrolizumab-based-neoadjuvant-therapy-for-triple-negative-breast-cancer-a-case-report.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.7759/cureus.119448","doi":"https://doi.org/10.7759/cureus.119448","is_oa":true,"landing_page_url":"https://doi.org/10.7759/cureus.119448","pdf_url":"https://www.cureus.com/articles/535740-unilateral-calf-swelling-and-skin-induration-during-pembrolizumab-based-neoadjuvant-therapy-for-triple-negative-breast-cancer-a-case-report.pdf","source":{"id":"https://openalex.org/S2738950867","display_name":"Cureus","issn_l":"2168-8184","issn":["2168-8184"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-20","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310316779","host_organization_name":"Cureus, Inc.","host_organization_lineage":["https://openalex.org/P4310316779"],"host_organization_lineage_names":["Cureus, Inc."],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cureus","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225835259.pdf","grobid_xml":"https://content.openalex.org/works/W7225835259.grobid-xml"},"referenced_works_count":19,"referenced_works":["https://openalex.org/W2022021153","https://openalex.org/W2056600843","https://openalex.org/W2104484646","https://openalex.org/W2565782504","https://openalex.org/W2618058692","https://openalex.org/W2753783846","https://openalex.org/W2771843743","https://openalex.org/W2783137027","https://openalex.org/W2806304077","https://openalex.org/W2980443636","https://openalex.org/W3092823831","https://openalex.org/W3097366821","https://openalex.org/W3210474759","https://openalex.org/W4210957314","https://openalex.org/W4295066960","https://openalex.org/W4306692674","https://openalex.org/W7163896844","https://openalex.org/W7167353899","https://openalex.org/W7170192956"],"related_works":[],"abstract_inverted_index":{"Eosinophilic":[0],"fasciitis":[1],"(EF)":[2],"is":[3],"a":[4,22,58,127],"rare":[5],"fibro-inflammatory":[6],"disorder":[7],"that":[8],"has":[9],"been":[10],"reported":[11],"following":[12],"immune":[13],"checkpoint":[14],"inhibitor":[15],"(ICI)":[16],"therapy.We":[17],"report":[18],"the":[19,114,158,204],"case":[20,202],"of":[21,67,101,131,139,176,206,209],"woman":[23],"in":[24,137],"her":[25],"70s":[26],"with":[27,174],"locally":[28],"advanced":[29],"triplenegative":[30],"breast":[31],"cancer":[32],"(TNBC)":[33],"who":[34],"developed":[35],"acute":[36],"unilateral":[37],"calf":[38],"pain,":[39,177],"erythema,":[40,107,178],"swelling,":[41],"and":[42,57,73,108,113,151,179,181,187,193,213,223],"woody":[43,214],"skin":[44,122,184,215],"induration":[45,123,216],"approximately":[46,154],"four":[47,155],"months":[48,156,166],"after":[49,91,145,167],"commencing":[50],"neoadjuvant":[51],"pembrolizumab-based":[52],"therapy.Investigations":[53],"demonstrated":[54],"peripheral":[55],"eosinophilia":[56],"normal":[59],"creatine":[60],"kinase":[61],"(CK)":[62],"level.Pembrolizumab":[63],"was":[64,76,134,142,148,197],"withheld":[65],"because":[66],"initial":[68],"concern":[69],"for":[70,160],"ICI-associated":[71],"myositis,":[72],"oral":[74],"prednisolone":[75],"commenced":[77],"at":[78],"60":[79],"mg":[80],"daily":[81],"(approximately":[82],"1":[83],"mg/kg).Magnetic":[84],"resonance":[85],"imaging":[86],"(MRI)":[87],"performed":[88],"19":[89],"days":[90],"corticosteroid":[92,119,224],"initiation":[93],"showed":[94],"mild":[95],"subcutaneous":[96],"soft-tissue":[97],"edema":[98],"without":[99,157],"evidence":[100],"myositis":[102],"or":[103],"characteristic":[104],"fascial":[105],"abnormalities.Pain,":[106],"swelling":[109,180,212],"improved":[110],"within":[111],"days,":[112],"eosinophil":[115],"count":[116],"fell":[117],"during":[118,217],"treatment,":[120],"although":[121],"persisted.Rheumatology":[124],"assessment":[125,208],"supported":[126],"clinical":[128,140],"working":[129],"diagnosis":[130],"suspected":[132],"EF.Biopsy":[133],"not":[135,227],"pursued":[136],"view":[138],"improvement.Pembrolizumab":[141],"permanently":[143],"discontinued":[144,152],"multidisciplinary":[146],"discussion.Prednisolone":[147],"gradually":[149],"tapered":[150],"over":[153],"need":[159],"additional":[161],"immunosuppression.At":[162],"last":[163],"review,":[164],"five":[165],"symptom":[168],"onset,":[169],"she":[170],"remained":[171,190],"off":[172],"corticosteroids,":[173],"resolution":[175],"only":[182],"residual":[183],"induration.Paclitaxel-associated":[185],"sclerosis":[186],"morphoea":[188],"profunda":[189],"competing":[191],"explanations,":[192],"attribution":[194],"to":[195],"pembrolizumab":[196],"possible":[198],"rather":[199],"than":[200],"established.This":[201],"highlights":[203],"importance":[205],"specialist":[207],"unexplained":[210],"limb":[211],"combination":[218],"anticancer":[219],"therapy.Normal":[220],"CK":[221],"levels":[222],"responsiveness":[225],"do":[226],"establish":[228],"EF.":[229]},"counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2026-11-12T00:00:00"}